Universidad Autónoma de Madrid-ko ikertzaileekin lankidetzan egindako argitalpenak (4)

2011

  1. Somatotroph tumor progression during pegvisomant therapy: A clinical and molecular study

    Journal of Clinical Endocrinology and Metabolism, Vol. 96, Núm. 2

2010

  1. Pegvisomant-induced liver injury is related to the UGT1A1*28 polymorphism of Gilbert's syndrome

    Journal of Clinical Endocrinology and Metabolism, Vol. 95, Núm. 5, pp. 2147-2154

  2. The exon 3-deleted growth hormone receptor is associated with better response to pegvisomant therapy in acromegaly

    Journal of Clinical Endocrinology and Metabolism, Vol. 95, Núm. 1, pp. 222-229

2008

  1. 99MTc-Sestamibi as sole technique in selection of primary hyperparathyroidism patients for unilateral neck exploration

    Surgery, Vol. 144, Núm. 3, pp. 454-459